Tomer M Mark, Morton Coleman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Clarithromycin/pharmacologyClarithromycin/therapeutic useHumansImmunosuppressive Agents/pharmacologyImmunosuppressive Agents/therapeutic useMultiple Myeloma/drug therapyThalidomide/therapeutic use
Substances: See more » Immunosuppressive AgentsThalidomideClarithromycin
Year: 2015 PMID: 26505907 DOI: 10.1159/000440874
Source DB: PubMed Journal: Acta Haematol ISSN: 0001-5792 Impact factor: 2.195